Fiscal Year:
2001
Title:
Prevention of Restenosis with a Novel Radiation Catheter
Agency:
HHS
Contract:
N/A
Award Amount:
$102,500.00
Abstract:
DESCRIPTION (PROVIDED BY APPLICANT): Angioplasty is a widely accepted
non-surgical method to treat patients with coronary artery disease. It is
estimated that over 700,000 angioplasty procedures were performed in 1999
worldwide. Restenosis is a common complication of angioplasty and occurs in
20-50 percent of these procedures. RadioVascular Systems (RVS) has a unique
radioactive catheter that can be used to prevent restenosis after angioplasty
in coronary and peripheral arteries. The RVS catheter is superior to its
competition because it does not require centering or ultrasound, does not
occlude blood flow, requires less radioactivity than other catheters and can be
manufactured at a reasonable cost. The market for intravascular radiation is
estimated to grow to over $300 million in year 2002. The experiments described
in this proposal are designed to prove feasibility of a prototype catheter in
an established animal model of restenosis.
PROPOSED COMMERCIAL APPLICATION:
The potential commercial applications of the research are immediate. The data from these
experiments will be used to perfect the design of the catheter that will be used in clinical
trials. Other applications of this research are related to the development of new devices
for the treatment of cancer.
Principal Investigator:
Neal A. Scott
Small Business Information at Submission:
RADIOVASCULAR SYSTEMS, LLC
1050 17TH NW, STE 600 WASHINGTON, DC 20036
EIN/Tax ID:
522291392
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned:
No
Minority-Owned:
No
HUBZone-Owned:
No